Role and expression patterns of E-cadherin in head and neck squamous cell carcinoma (HNSCC)

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 1, 2006, Pages 5-14

  Georgolios, A ^a   Batistatou, A ^a   Manolopoulos, L ^b   Charalabopoulos, K ^a,c  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c NONE   (Greece)

Author keywords

Adhesion molecules; Cancer; E cadherin; Head and neck squamous cell carcinoma

Indexed keywords

CELL ADHESION MOLECULE; UVOMORULIN;

CANCER INVASION; CANCER RESEARCH; CARCINOGENESIS; CARCINOMA IN SITU; CELL ADHESION; CELL INTERACTION; DYSPLASIA; HEAD AND NECK CARCINOMA; HUMAN; HYPERPLASIA; LARYNX CANCER; METASTASIS; NASOPHARYNX CANCER; PHARYNX CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

ANIMALS; CADHERINS; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; PROGNOSIS;

EID: 33646076700     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Aberle H., Schwartz H., Kemler R.: Cadherin- Catenin Complex: Protein interactions and their implications for cadherin function. J. Cellular Biochem. 61:514-523, 1996.
2. Lewis J., Jensen P., Johnson K., et al.: E- cadherin mediates adherens junction organization through protein kinase C. J. Cell Sci. 108:3615-3621, 1995.
3. Overduin M., Harvey T.S., Bagby S. et al.: Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science 267(5196):386-389, 1995.
4. Noe V., Willems J., Vandekerckhove J., et al.: Inhibition of adhesion and induction of epithelial cell invasion by HAV- containing E- cadherin-specific peptides. J. Cell Sci. 112 (Pt 1): 127-135, 1999.
5. Mareel M., Berx G., Van Roy R, et al.: Cadherin / Catenin complex: A target for antiinvasive therapy? J. Cellular Biochem. 61:524-530, 1996.
6. Shapiro L., Fannon A.M., Kwong P.D., et al.: Structural basis of cell-cell adhesion by cadherins. Nature 374(6520):327-337, 1995.
7. Beavon I.: The E- cadherin- catenin complex in tumour metastasis. Eur. J. Cancer 36:1607-1620, 2000.
8. Yap A., Brieher W., Pruschy M., et al.: Lateral clustering of the adhesive ectodomain: a fundamental determinant of cadherin function. Curr. Biol. 7:308-315, 1997.
9. Renaud-Young M., Gallin W.J.: In the first extracellular domain of E-cadherin, heterophilic interactions, but not the conserved His-Ala-Val motif, are required for adhesion. J. Biol. Chem. 277(42):39609-39616, 2000.
10. Haussinger D., Ahrens T., Sass H.J., et al.: Calcium-dependent homoassociation of E-cadherin by NMR spectroscopy: changes in mobility, conformation and mapping of contact regions. J. Mol. Biol. 324(4):823-839, 2002.
11. Pertz O., Bozic D., Koch A.W., et al.: A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation. EMBO J. 18(7):1738-1747, 1999.
12. Katayama M., Hirai S., Kamihagi K., et al.: Soluble E-cadherin fragments increased in circulation of cancer patients. Br. J. Cancer 69(3):580-585, 1994.
13. Gofuku J., Shiozaki H., Doki Y, et al.: Characterisation of soluble E-cadherin as a disease marker in gastric cancer patients. Br. J. Cancer 78(8):1095-101, 1998.
14. Velikova G., Banks R.E., Gearing A., et al.: Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer. Br. J. Cancer 76(11):1398-1404, 1997.
15. Velikova G., Banks R.E., Gearing A., et al.: Serum concentrations of soluble adhesion molecules in patients with colorectal cancer. Br. J. Cancer 77(11):1857-1863, 1998.
16. Carvalho A.L., Nishimoto I.N., Califano J.A., et al.: Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database. Int. J. Cancer 114(5):806-816, 2005.
17. Califano J., van der Riet P., Westra W., et al.: Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 56(11):2488-2492, 1996.
18. Williams H.: Molecular pathogenesis of oral squamous carcinoma. J. Clin. Pathol. Mol. Pathol. 53:165-172, 2000.
19. Voravud N., Charuruks N., Mutirangura A.: Squamous cell carcinoma of head and neck. J. Med. Assoc. Thai. 80(4):207-218, 1997.
20. Perl A.K., Wilgenbus P., Dahl U., et al.: A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392:190-193, 1998.
21. Wu H., Lotan R., Menter D., Lippman S.M., Xu X.C.: Expression of E- cadherin is associated with squanous differentiation in squamous cell carcinomas. Anticancer Res. 20(3A): 1385-1390, 2000.
22. Sorscher S.M., Russack V., Cagle M., et al.: Immunolocalization of E- cadherin in human head and neck cancer. Arch. Pathol. Lab. Med. 119(1):82-84, 1995.
23. Bremnes R.M., Veve R., Gabrielson E., et al.: High- throughout tissue microarray analysis used to evaluate biology and prognostic significance of the E- cadherin pathway in non-small cell lung cancer. J. Clin. Oncol. 20(10):2417-2428, 2002.
24. Choi Y.S., Shim Y.M., Kim S.H., et al.: Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer. Eur. J. Cardiothorac. Surg. 24(3):441-449, 2003.
25. Horvath L.G., Henshall S.M., Lee C.S., et al.: Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer. Int. J. Cancer 113(3):415-422, 2005.
26. Kremmidiotis G., Baker E., Crawford J., et al.: Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity. Genomics 49(3):467-471, 1998.
27. Li C., Berx G., Larsson C., et al.: Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer. Gen. Chrom. Cancer 24(3):175-182, 1999.
28. Oda T., Kanai Y., Oyama T., et al.: E-cadherin gene mutations in human gastric carcinoma cell lines. Proc. Natl. Acad. Sci. U S A. 91(5):1858-1862, 1994.
29. Chen Q., Lipkina G., Song Q., et al.: Promoter methylation regulates cadherin switching in squamous cell carcinoma. Biochem. Biophys. Res. Commun. 315(4):850-856, 2004.
30. Kudo Y., Kitajima S., Ogawa I., et al.: Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin. Cancer Res. 10(16):5455-5463, 2004.
31. Viswanathan M., Tsuchida N., Shanmugam G.: Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int. J. Cancer 105(1):41-46, 2003.
32. Takes R.P., Baatenburg de Jong R.J., Schuuring E., Litvinov S.V., Hermans J., Van Krieken JH.: Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell. Anticancer Res. 18(6B):4793-4800, 1998.
33. Schipper J.H., Frixen U.H., Behrens J., et al.: E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 51(23 Pt 1):6328-6337, 1991.
34. Hernandez Gaspar R., de los Toyos J.R., Alvarez Marcos C., et al.: Quantitative immunohistochemical analyses of the expression of E-cadherin, thrombomodulin, CD44H and CD44v6 in primary tumours of pharynx/larynx squamous cell carcinoma and their lymph node metastases. Anal. Cell Pathol. 18(4):183-190, 1999.
35. Liu M., Lawson G., Delos M., et al.: Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx. Eur. Arch. Otorhinolaryngol. 260(1):28-34, 2003.
36. Rodrigo J.P., Dominguez F., Alvarez C., et al.: Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features. Eur. J. Cancer 38(8):1059-1064, 2002.
37. Andrews N.A., Jones A.S., Helliwell T.R., et al.: Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br. J. Cancer 75(10):1474-1480, 1997.
38. Takes R.P., Baatenburg de Jong R.J., Schuuring E., et al.: Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch. Otolaryngol. Head Neck Surg. 123(4):412-419, 1997.
39. Eriksen J.G., Steiniche T., Sogaard H., et al.: Expression of integrins and E-cadherin in squamous cell carcinomas of the head and neck. APMIS 112(9):560-568, 2004.
40. Mattijssen V., Peters H.M., Schalkwijk L., et al.: E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int. J. Cancer 55(4):580-585, 1993.
41. Bosch F.X., Andl C., Abel U., et al.: E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: A comparison of E-cadherin with desmosomal components. Int. J. Cancer 114(5):779-790, 2005.
42. Eriksen J.G., Buffa F.M., Alsner J., et al.: Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas. Radiother. Oncol. 72(3):275-282, 2004.
43. Buckley J.G., Feber T.: Surgical treatment of cervical node metastases from squamous carcinoma of the upper aerodigestive tract: evaluation of the evidence for modifications of neck dissection. Head Neck 23(10):907-915, 2001.
44. Shah J.P.: Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am. J. Surg. 160(4):405-409, 1990.
45. Kawano T., Nakamura Y., Yanoma S., et al.: Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer. Auris Nasus Larynx. 31(1):35-41, 2004.
46. Zheng Z., Pan J., Chu B., et al.: Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum. Pathol. 30(4):458-466, 1999.
47. Huang G.W., Mo W.N., Kuang G.Q., et al.: Expression of p16, nm23-H1, E-cadherin, and CD44 gene products and their significance in nasopharyngeal carcinoma. Laryngoscope 111(8):1465-1471, 2001.
48. Farwell D.G., McDougall J.K., Coltrera M.D.: Expression of Epstein-Barr virus latent membrane proteins leads to changes in keratinocyte cell adhesion. Ann. Otol. Rhinol. Laryngol. 108(9):851-859, 1999.
49. Yoshizaki T.: Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1. Histol. Histopathol. 17(3):845-850, 2002.
50. Tsao S.W., Liu Y., Wang X., et al.: The association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells. Eur. J. Cancer 39(4):524-531, 2003.
51. Kao R., Huang L.C., Hsu Y.H.: Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma. Anticancer Res. 22(6C):4109-4113, 2002.
52. Tsai C.N., Tsai C.L., Tse K.P., et al.: The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc. Natl. Acad. Sci. U S A. 99(15):1084-1089, 2002.
53. Hoteiya T., Hayashi E., Satomura K., et al.: Expression of E-cadherin in oral cancer cell lines and its relationship to invasiveness in SCID mice in vivo. J. Oral. Pathol. Med. 28(3): 107-111, 1999.
54. Gasparoni A., Fonzi L., Schneider G.B. et al.: Comparison of differentiation markers between normal and two squamous cell carcinoma cell lines in culture. Arch. Oral. Biol. 49(8):653-664, 2004.
55. Sakaki T., Tamura I., Kadota H., et al.: Changing expression of E- and P- cadherin during rat tongue carcinogenesis induced by 4- nitroquinoline 1- oxide. J. Oral. Pathol. Med. 32(9): 530-537, 2003.
56. Shinohara M., Hiraki A., Ikebe T., et al.: Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour. J. Pathol. 184(4):369-381, 1998.
57. Downer C.S., Speight P.M.: E- cadherin expression in normal, hyperplastic and malignant oral epithelium. Eur. J. B. Oral. Oncol. 29B(4):303-305, 1993.
58. Yamada K., Jordan R., Mori M., et al.: The relationship between E-cadherin expression, clinical stage and tumour differentiation in oral squamous cell carcinoma. Oral Dis. 3(2):82-85, 1997.
59. Bankfalvi A., Krassort M., Vegh A., et al.: Deranged expression of the E- cadherin/beta- catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J. Oral. Pathol. Med. 31(8):450-457, 2002.
60. Massarelli E., Brown E., Tran N., et al.: Loss of E- cadherin and p- 27 expression is associated with head and neck tumorigenesis. Cancer 103(5):952-959, 2005.
61. Lim S.C., Zhang S., Ishii G., et al.: Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin. Cancer Res. 10(1 Pt 1):166-172, 2004.
62. Chang H.W., Chow V., Lam K.Y., et al.: Loss of E- cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer 94 (2):386-392, 2002.
63. Okamoto M., Nishimine M., Kishi M., et al.: Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue. J. Oral. Pathol. Med. 31(4):227-233, 2002.
64. Lo Muzio, Staibano S., Pannone G., et al.: Beta- and gamma catenin expression in oral squamous cell carcinomas. Anticancer Res. 19(5B):3817-3826, 1999.
65. Chow V., Yuen A.P., Lam K.Y., et al.: A comparative study of the clinicopathological significance of E- cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma. J. Cancer Res. Clin. Oncol. 127(1):59-63, 2001.
66. Lo Muzio L., Pannone G., Staibano S., et al.: p120 (cat) delocalization in cell lines of oral cancer. Oral Oncol. 38(1):64-72, 2002.
67. Shnayder Y., Kuriakose M.A., Yee H., et al.: Adhesion molecules as prognostic factors in nasopharyngeal carcinoma. Laryngoscope 111(10):1842-1846, 2001.
68. Litvinov S.V., van Driel W., van Rhijn C.M., et al.: Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Am. J. Pathol. 148(3):865-875, 1996.
69. de Boer C.J., van Dorst E., van Krieken H., et al.: Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. Am. J. Pathol. 155(2):505-515, 1999.
70. Songun I., van de Velde C.J., Hermans J., et al.: Expression of oncoproteins and the amount of eosinophilic and lymphocytic infiltrates can be used as prognostic factors in gastric cancer. Br. J. Cancer 74(11):1783-1788, 1996.
71. Okamoto M., Nishimine M., Kishi M., et al.: Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue. J. Oral Pathol. Med. 31(4):227-233, 2002.
72. van den Brekel M.W., Bindels E.M., Balm A.J.: Prognostic factors in head and neck cancer. Eur. J. Cancer 38(8):1041-1043, 2002.
73. Mori S., Nose M., Morikawa H., et al.: A novel evaluation system of metastatic potential of oral squamous cell carcinoma according to the histopathological and histochemical grading. Oral Oncol. 34(6):549-557, 1998.